Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nuo Therapeutics's enterprise value was $60.56M on Oct 19, 2026, against $93.34M a year earlier. Over the last 5 years it ranged from -$1.41M to $158.83M, with a median of $55.53M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $60.56M | -35.4% |
| 2025 | Dec 31, 2025 | $93.81M | +45.3% |
| 2024 | Dec 31, 2024 | $64.55M | +184.5% |
| 2023 | Dec 29, 2023 | $22.69M | -62.1% |
| 2022 | Dec 30, 2022 | $59.82M | – |
| 2021 | Dec 31, 2021 | -$145.40K | -101.3% |
| 2020 | Dec 31, 2020 | $10.91M | +285.6% |
| 2019 | Dec 31, 2019 | $2.83M | +304.9% |
| 2018 | Dec 31, 2018 | $698.73K | -32.3% |
| 2017 | Dec 29, 2017 | $1.03M | – |
See a number that looks wrong?